BLRX Share Price

Open 1.00 Change Price %
High 1.01 1 Day -0.03 -2.97
Low 0.98 1 Week -0.10 -9.26
Close 0.98 1 Month -0.04 -3.92
Volume 217428 1 Year -0.56 -36.36
52 Week High 1.45
52 Week Low 0.00
BLRX Important Levels
Resistance 2 1.01
Resistance 1 1.00
Pivot 0.99
Support 1 0.96
Support 2 0.95
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

BioLineRx Ltd. (NASDAQ: BLRX)

BLRX Technical Analysis 2
As on 2nd Dec 2016 BLRX Share Price closed @ 0.98 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.98 & Strong Sell for SHORT-TERM with Stoploss of 1.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
BLRX Target for December
1st Target up-side 1.13
2nd Target up-side 1.21
3rd Target up-side 1.28
1st Target down-side 0.91
2nd Target down-side 0.83
3rd Target down-side 0.76
BioLineRx Ltd. ( NASDAQ USA Symbol : BLRX )
Sector : N/AIndustry:N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. The company And Other Stocks in Same Sector
BLRX
0.98 -0.03 (-2.97 %)
LT : Buy
ST : Strong Sell
BLRX Other Details
Segment EQ
Market Capital 52288676.00
Sector N/AIndustry:N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. The company
Industry N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical de
Offical website http://www.biolinerx.com
BLRX Address
BLRX
19 Hartum Street
PO Box 45158
Jerusalem, 91450
Israel
Phone: 972 2 548 9100
Fax: 972 2 548 9101
Interactive Technical Analysis Chart BioLineRx Ltd. ( BLRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BioLineRx Ltd.
BLRX Business Profile
BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in schizophrenia patients; BL-1040, which is under pivotal CE-Mark registration trial for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, which has completed Phase I/II clinical trials for non-surgical removal of skin lesions; BL-1021 that has completed Phase Ia clinical trial for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is in Phase II clinical trial for the treatment of inflammatory bowel disease. The Company also has 11 pre-clinical stage development products for various indications. More from Reuters »